"Effects of Ranolazine on Angina and Quality of Life After Percutaneous Coronary Intervention With Incomplete Revascularization"
"Conclusions—Despite ICR following PCI, there was no incremental benefit in angina or QOL measures by adding ranolazine in this angiographically-identified population. These measures markedly improved within 1 month of PCI and persisted up to 1 year in both treatment arms."
http://circ.ahajournals.org/content/133/1/39.full
Thursday, December 31, 2015
Wednesday, December 30, 2015
BMJ - "Long term trends in prevalence of neural tube defects in Europe: population based study"
"Long term trends in prevalence of neural tube defects in Europe: population based study"
"What this study adds In the absence of mandatory fortification, the prevalence of NTD has not decreased in Europe despite longstanding recommendations aimed at promoting peri-conceptional folic acid supplementation and existence of voluntary folic acid fortification."
http://www.bmj.com/content/351/bmj.h5949
"What this study adds In the absence of mandatory fortification, the prevalence of NTD has not decreased in Europe despite longstanding recommendations aimed at promoting peri-conceptional folic acid supplementation and existence of voluntary folic acid fortification."
http://www.bmj.com/content/351/bmj.h5949
Tuesday, December 29, 2015
NEJM - "Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection"
"Azithromycin versus Doxycycline for Urogenital Chlamydia trachomatis Infection"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1502599
"CONCLUSIONS
In the context of a closed population receiving directly observed treatment for urogenital chlamydia infection, the efficacy of azithromycin was 97%, and the efficacy of doxycycline was 100%. The noninferiority of azithromycin was not established in this setting. (Funded by the National Institute of Allergy and Infectious Diseases; ClinicalTrials.gov number, NCT00980148.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1502599
Monday, December 28, 2015
JAMA - "Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival"
"Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival"
"Conclusions and Relevance Among premenopausal women with either hormone receptor–positive or hormone receptor–negative breast cancer, concurrent administration of triptorelin and chemotherapy, compared with chemotherapy alone, was associated with higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate. There was no statistically significant difference in DFS for women assigned to triptorelin and those assigned to chemotherapy alone, although study power was limited."
http://jama.jamanetwork.com/article.aspx?articleid=2478203
"Conclusions and Relevance Among premenopausal women with either hormone receptor–positive or hormone receptor–negative breast cancer, concurrent administration of triptorelin and chemotherapy, compared with chemotherapy alone, was associated with higher long-term probability of ovarian function recovery, without a statistically significant difference in pregnancy rate. There was no statistically significant difference in DFS for women assigned to triptorelin and those assigned to chemotherapy alone, although study power was limited."
http://jama.jamanetwork.com/article.aspx?articleid=2478203
Friday, December 25, 2015
Weekly Guideline - "AHA Scientific Statement Cardiac Arrest in Pregnancy"
"AHA Scientific Statement Cardiac Arrest in Pregnancy"
http://circ.ahajournals.org/content/132/18/1747
http://circ.ahajournals.org/content/132/18/1747
Thursday, December 24, 2015
JACC - "Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement"
"Bivalirudin Versus Heparin Anticoagulation in Transcatheter Aortic Valve Replacement"
"Conclusions In this randomized trial of TAVR procedural pharmacotherapy, bivalirudin did not reduce rates of major bleeding at 48 h or net adverse cardiovascular events within 30 days compared with heparin. Although superiority was not shown, the noninferiority hypothesis was met with respect to the latter factor. Given the lower cost, heparin should remain the standard of care, and bivalirudin can be an alternative anticoagulant option in patients unable to receive heparin in TAVR"
http://content.onlinejacc.org/article.aspx?articleID=2461781
"Conclusions In this randomized trial of TAVR procedural pharmacotherapy, bivalirudin did not reduce rates of major bleeding at 48 h or net adverse cardiovascular events within 30 days compared with heparin. Although superiority was not shown, the noninferiority hypothesis was met with respect to the latter factor. Given the lower cost, heparin should remain the standard of care, and bivalirudin can be an alternative anticoagulant option in patients unable to receive heparin in TAVR"
http://content.onlinejacc.org/article.aspx?articleID=2461781
Wednesday, December 23, 2015
BMJ - "Association between day of delivery and obstetric outcomes: observational study"
"Association between day of delivery and obstetric outcomes: observational study"
"What this study adds This study provides an evaluation of the “weekend effect” in obstetric care, covering a range of outcomes. The results would suggest approximately 770 perinatal deaths and 470 maternal infections per year above what might be expected if performance was consistent across women admitted, and babies born, on different days of the week."
http://www.bmj.com/content/351/bmj.h5774
"What this study adds This study provides an evaluation of the “weekend effect” in obstetric care, covering a range of outcomes. The results would suggest approximately 770 perinatal deaths and 470 maternal infections per year above what might be expected if performance was consistent across women admitted, and babies born, on different days of the week."
http://www.bmj.com/content/351/bmj.h5774
Tuesday, December 22, 2015
NEJM - "Hypothermia for Intracranial Hypertension after Traumatic Brain Injury"
"Hypothermia for Intracranial Hypertension after Traumatic Brain Injury"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1507581?query=featured_home
"CONCLUSIONS
In patients with an intracranial pressure of more than 20 mm Hg after traumatic brain injury, therapeutic hypothermia plus standard care to reduce intracranial pressure did not result in outcomes better than those with standard care alone. (Funded by the National Institute for Health Research Health Technology Assessment program; Current Controlled Trials number, ISRCTN34555414.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1507581?query=featured_home
Monday, December 21, 2015
JAMA - "Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia"
"Effect of Transfusion of Red Blood Cells With Longer vs Shorter Storage Duration on Elevated Blood Lactate Levels in Children With Severe Anemia"
"Conclusions and Relevance Among children with lactic acidosis due to severe anemia, transfusion of longer-storage compared with shorter-storage RBC units did not result in inferior reduction of elevated blood lactate levels. These findings have relevance regarding the efficacy of stored RBC transfusion for patients with critical tissue hypoxia and lactic acidosis due to anemia."
http://jama.jamanetwork.com/article.aspx?articleid=2472941
"Conclusions and Relevance Among children with lactic acidosis due to severe anemia, transfusion of longer-storage compared with shorter-storage RBC units did not result in inferior reduction of elevated blood lactate levels. These findings have relevance regarding the efficacy of stored RBC transfusion for patients with critical tissue hypoxia and lactic acidosis due to anemia."
http://jama.jamanetwork.com/article.aspx?articleid=2472941
Friday, December 18, 2015
Weekly Guideline -"2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction "
"2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction:
An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction "
http://circ.ahajournals.org/content/early/2015/10/20/CIR.0000000000000336
An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction "
http://circ.ahajournals.org/content/early/2015/10/20/CIR.0000000000000336
Thursday, December 17, 2015
JACC - "Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis"
"Initial Surgical Versus Conservative Strategies in Patients With Asymptomatic Severe Aortic Stenosis"
"Conclusions The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140)"
http://content.onlinejacc.org/article.aspx?articleID=2457337
"Conclusions The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140)"
http://content.onlinejacc.org/article.aspx?articleID=2457337
Wednesday, December 16, 2015
BMJ - "Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis"
"Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis"
"What this study adds A substantial positive association was seen between use of warfarin with glipizide/glimepiride and hospital admission/emergency department visits for hypoglycemia and related diagnoses, particularly in patients starting warfarin. The findings suggest the possibility of a significant drug interaction between these medications."
http://www.bmj.com/content/351/bmj.h6223
"What this study adds A substantial positive association was seen between use of warfarin with glipizide/glimepiride and hospital admission/emergency department visits for hypoglycemia and related diagnoses, particularly in patients starting warfarin. The findings suggest the possibility of a significant drug interaction between these medications."
http://www.bmj.com/content/351/bmj.h6223
Tuesday, December 15, 2015
NEJM - "Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation"
"Endobronchial Valves for Emphysema without Interlobar Collateral Ventilation"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1507807?query=featured_home
"CONCLUSIONS
Endobronchial-valve treatment significantly improved pulmonary function and exercise capacity in patients with severe emphysema characterized by an absence of interlobar collateral ventilation. (Funded by the Netherlands Organization for Health Research and Development and the University Medical Center Groningen; Netherlands Trial Register number, NTR2876.)"
Monday, December 14, 2015
JAMA - "Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products"
"Comparative Risk of Anaphylactic Reactions Associated With Intravenous Iron Products"
"Conclusions and Relevance Among patients in the US Medicare nondialysis population with first exposure to IV iron, the risk of anaphylaxis was highest for iron dextran and lowest for iron sucrose.
http://jama.jamanetwork.com/article.aspx?articleid=2470447
"Conclusions and Relevance Among patients in the US Medicare nondialysis population with first exposure to IV iron, the risk of anaphylaxis was highest for iron dextran and lowest for iron sucrose.
http://jama.jamanetwork.com/article.aspx?articleid=2470447
Friday, December 11, 2015
Thursday, December 10, 2015
CIRC - "Extracorporeal-Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest is Associated with Improved Survival to Discharge: A Report from the American Heart Association's Get With the Guidelines® - Resuscitation Registry"
"Extracorporeal-Cardiopulmonary Resuscitation (E-CPR) During Pediatric In-Hospital Cardiopulmonary Arrest is Associated with Improved Survival to Discharge: A Report from the American Heart Association's Get With the Guidelines® - Resuscitation Registry"
"Conclusions—For children with in-hospital CPR ≥ 10 minutes duration, E-CPR was associated with improved survival to hospital discharge and survival with favorable neurologic outcome when compared to C-CPR."
http://circ.ahajournals.org/content/early/2015/12/03/CIRCULATIONAHA.115.016082.abstract
"Conclusions—For children with in-hospital CPR ≥ 10 minutes duration, E-CPR was associated with improved survival to hospital discharge and survival with favorable neurologic outcome when compared to C-CPR."
http://circ.ahajournals.org/content/early/2015/12/03/CIRCULATIONAHA.115.016082.abstract
Wednesday, December 9, 2015
BMJ - "Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study"
"Safety of live attenuated influenza vaccine in young people with egg allergy: multicentre prospective cohort study"
"Study answer and limitations No systemic allergic reactions occurred (upper 95% confidence interval for population 0.47% and in participants with anaphylaxis to egg 1.36%). Nine participants (1.2%, 95% CI 0.5% to 2.2%) experienced mild symptoms, potentially consistent with a local, IgE mediated allergic reaction. Delayed events potentially related to the vaccine were reported in 221 participants. 62 participants (8.1%, 95% CI for population 6.3% to 10.3%) experienced lower respiratory tract symptoms within 72 hours, including 29 with parent reported wheeze. No participants were admitted to hospital. No increase in lower respiratory tract symptoms occurred in the four weeks after vaccination (assessed with asthma control test). The study cohort may represent young people with more severe allergy requiring specialist input, since they were recruited from secondary and tertiary allergy centres.
"Study answer and limitations No systemic allergic reactions occurred (upper 95% confidence interval for population 0.47% and in participants with anaphylaxis to egg 1.36%). Nine participants (1.2%, 95% CI 0.5% to 2.2%) experienced mild symptoms, potentially consistent with a local, IgE mediated allergic reaction. Delayed events potentially related to the vaccine were reported in 221 participants. 62 participants (8.1%, 95% CI for population 6.3% to 10.3%) experienced lower respiratory tract symptoms within 72 hours, including 29 with parent reported wheeze. No participants were admitted to hospital. No increase in lower respiratory tract symptoms occurred in the four weeks after vaccination (assessed with asthma control test). The study cohort may represent young people with more severe allergy requiring specialist input, since they were recruited from secondary and tertiary allergy centres.
What this study adds LAIV is associated with a low risk of systemic allergic reactions in young people with egg allergy. The vaccine seems to be well tolerated in those with well controlled asthma or recurrent wheeze."
http://www.bmj.com/content/351/bmj.h6291
Tuesday, December 8, 2015
NEJM - "Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction"
"Isosorbide Mononitrate in Heart Failure with Preserved Ejection Fraction"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1510774?query=featured_home
"CONCLUSIONS
Patients with heart failure and a preserved ejection fraction who received isosorbide mononitrate were less active and did not have better quality of life or submaximal exercise capacity than did patients who received placebo. (Funded by the National Heart, Lung, and Blood Institute; ClinicalTrials.gov number, NCT02053493.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1510774?query=featured_home
Monday, December 7, 2015
JAMA - "Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction"
"Effect of Vericiguat, a Soluble Guanylate Cyclase Stimulator, on Natriuretic Peptide Levels in Patients With Worsening Chronic Heart Failure and Reduced Ejection Fraction"
"Conclusions and Relevance Among patients with worsening chronic HF and reduced LVEF, compared with placebo, vericiguat did not have a statistically significant effect on change in NT-proBNP level at 12 weeks but was well-tolerated. Further clinical trials of vericiguat based on the dose-response relationship in this study are needed to determine the potential role of this drug for patients with worsening chronic HF.
http://jama.jamanetwork.com/article.aspx?articleid=2469195
"Conclusions and Relevance Among patients with worsening chronic HF and reduced LVEF, compared with placebo, vericiguat did not have a statistically significant effect on change in NT-proBNP level at 12 weeks but was well-tolerated. Further clinical trials of vericiguat based on the dose-response relationship in this study are needed to determine the potential role of this drug for patients with worsening chronic HF.
Trial Registration clinicaltrials.gov Identifier: NCT01951625"
http://jama.jamanetwork.com/article.aspx?articleid=2469195
Friday, December 4, 2015
Weekly Guideline - "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 7: Adult Advanced Cardiovascular Life Support"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Part 7: Adult Advanced Cardiovascular Life Support"
http://circ.ahajournals.org/content/132/18_suppl_2/S444.full
Part 7: Adult Advanced Cardiovascular Life Support"
http://circ.ahajournals.org/content/132/18_suppl_2/S444.full
Thursday, December 3, 2015
CIRC - "Association of Fruit and Vegetable Consumption During Early Adulthood With the Prevalence of Coronary Artery Calcium After 20 Years of Follow-Up"
"Association of Fruit and Vegetable Consumption During Early Adulthood With the Prevalence of Coronary Artery Calcium After 20 Years of Follow-Up"
"Conclusions—In this longitudinal cohort study, higher intake of F/V during young adulthood was associated with lower odds of prevalent coronary artery calcium after 20 years of follow-up. Our results reinforce the importance of establishing a high intake of F/V as part of a healthy dietary pattern early in life."
http://circ.ahajournals.org/content/132/21/1990.full
"Conclusions—In this longitudinal cohort study, higher intake of F/V during young adulthood was associated with lower odds of prevalent coronary artery calcium after 20 years of follow-up. Our results reinforce the importance of establishing a high intake of F/V as part of a healthy dietary pattern early in life."
http://circ.ahajournals.org/content/132/21/1990.full
Wednesday, December 2, 2015
BMJ - "Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents: Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials"
"Methylphenidate for attention-deficit/hyperactivity disorder in children and adolescents:
Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials"
"What this study adds The results suggest that among children and adolescents with a diagnosis of ADHD, methylphenidate may improve teacher reported symptoms of ADHD and general behaviour and parent reported quality of life. However, given the risk of bias in the included studies, and the very low quality of outcomes, the magnitude of the effects is uncertain. Methylphenidate is associated with an increased risk of non-serious but not serious adverse events."
http://www.bmj.com/content/351/bmj.h5203
Cochrane systematic review with meta-analyses and trial sequential analyses of randomised clinical trials"
"What this study adds The results suggest that among children and adolescents with a diagnosis of ADHD, methylphenidate may improve teacher reported symptoms of ADHD and general behaviour and parent reported quality of life. However, given the risk of bias in the included studies, and the very low quality of outcomes, the magnitude of the effects is uncertain. Methylphenidate is associated with an increased risk of non-serious but not serious adverse events."
http://www.bmj.com/content/351/bmj.h5203
Tuesday, December 1, 2015
NEJM - "A Randomized Trial of Intensive versus Standard Blood-Pressure Control"
"A Randomized Trial of Intensive versus Standard Blood-Pressure Control"
"CONCLUSIONS
"CONCLUSIONS
Among patients at high risk for cardiovascular events but without diabetes, targeting a systolic blood pressure of less than 120 mm Hg, as compared with less than 140 mm Hg, resulted in lower rates of fatal and nonfatal major cardiovascular events and death from any cause, although significantly higher rates of some adverse events were observed in the intensive-treatment group. (Funded by the National Institutes of Health; ClinicalTrials.gov number,NCT01206062.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1511939
Monday, November 30, 2015
JAMA - "Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy"
"Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy"
"Conclusions and Relevance Among eyes with proliferative diabetic retinopathy, treatment with ranibizumab resulted in visual acuity that was noninferior to (not worse than) PRP treatment at 2 years. Although longer-term follow-up is needed, ranibizumab may be a reasonable treatment alternative, at least through 2 years, for patients with proliferative diabetic retinopathy."
http://jama.jamanetwork.com/article.aspx?articleid=2469891
"Conclusions and Relevance Among eyes with proliferative diabetic retinopathy, treatment with ranibizumab resulted in visual acuity that was noninferior to (not worse than) PRP treatment at 2 years. Although longer-term follow-up is needed, ranibizumab may be a reasonable treatment alternative, at least through 2 years, for patients with proliferative diabetic retinopathy."
http://jama.jamanetwork.com/article.aspx?articleid=2469891
Friday, November 27, 2015
Weekly Guideline - "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care
Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation"
http://circ.ahajournals.org/content/132/18_suppl_2/S436.full
Part 6: Alternative Techniques and Ancillary Devices for Cardiopulmonary Resuscitation"
http://circ.ahajournals.org/content/132/18_suppl_2/S436.full
Thursday, November 26, 2015
CIRC - "Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack"
"Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack"
"Conclusions—Vorapaxar reduced cardiovascular death, MI, or stroke in stable patients with a history of previous MI, whether treated concomitantly with a thienopyridine or not. The relative risk of moderate or severe bleeding was similarly increased irrespective of thienopyridine use."
http://circ.ahajournals.org/content/132/20/1871.abstract
"Conclusions—Vorapaxar reduced cardiovascular death, MI, or stroke in stable patients with a history of previous MI, whether treated concomitantly with a thienopyridine or not. The relative risk of moderate or severe bleeding was similarly increased irrespective of thienopyridine use."
http://circ.ahajournals.org/content/132/20/1871.abstract
Wednesday, November 25, 2015
BMJ - "Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study"
"Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study"
"What this study adds Patients with type 1 or type 2 diabetes are at increased risk of blindness and amputation but generally do not have accurate assessments of the magnitude of their individual risks. The new algorithms calculate the absolute risk of developing these complications over a 10 year period in patients with diabetes, taking account of their individual risk factors."
http://www.bmj.com/content/351/bmj.h5441
"What this study adds Patients with type 1 or type 2 diabetes are at increased risk of blindness and amputation but generally do not have accurate assessments of the magnitude of their individual risks. The new algorithms calculate the absolute risk of developing these complications over a 10 year period in patients with diabetes, taking account of their individual risk factors."
http://www.bmj.com/content/351/bmj.h5441
Tuesday, November 24, 2015
NEJM - "Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk"
"Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1503943
"CONCLUSIONS
Among patients at high risk for bleeding who underwent PCI, a polymer-free umirolimus-coated stent was superior to a bare-metal stent with respect to the primary safety and efficacy end points when used with a 1-month course of dual antiplatelet therapy. (Funded by Biosensors Europe; LEADERS FREE ClinicalTrials.gov number,NCT01623180.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1503943
Monday, November 23, 2015
JAMA - "Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations"
"Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations"
"Conclusions and Relevance Both the incidence of early-stage prostate cancer and rates of PSA screening have declined and coincide with 2012 USPSTF recommendation to omit PSA screening from routine primary care for men. Longer follow-up is needed to see whether these decreases are associated with trends in mortality."
http://jama.jamanetwork.com/article.aspx?articleid=2470446
"Conclusions and Relevance Both the incidence of early-stage prostate cancer and rates of PSA screening have declined and coincide with 2012 USPSTF recommendation to omit PSA screening from routine primary care for men. Longer follow-up is needed to see whether these decreases are associated with trends in mortality."
http://jama.jamanetwork.com/article.aspx?articleid=2470446
Friday, November 20, 2015
Weekly Guideline - "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 5: Adult Basic Life Support and Cardiopulmonary Resuscitation Quality"
http://circ.ahajournals.org/content/132/18_suppl_2/S414.full
http://circ.ahajournals.org/content/132/18_suppl_2/S414.full
Thursday, November 19, 2015
CIRC - "Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus"
"Relation of Smoking With Total Mortality and Cardiovascular Events Among Patients With Diabetes Mellitus"
"Conclusions—Active smoking is associated with significantly increased risks of total mortality and cardiovascular events among diabetic patients, whereas smoking cessation is associated with reduced risks in comparison with current smoking. The findings provide strong evidence for the recommendation of quitting smoking among diabetic patients."
http://circ.ahajournals.org/content/132/19/1795.full
"Conclusions—Active smoking is associated with significantly increased risks of total mortality and cardiovascular events among diabetic patients, whereas smoking cessation is associated with reduced risks in comparison with current smoking. The findings provide strong evidence for the recommendation of quitting smoking among diabetic patients."
http://circ.ahajournals.org/content/132/19/1795.full
Wednesday, November 18, 2015
BMJ - "Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial"
"Computerised cognitive behaviour therapy (cCBT) as treatment for depression in primary care (REEACT trial): large scale pragmatic randomised controlled trial"
"What this study adds Supported cCBT does not substantially improve depression outcomes compared with usual GP care alone. In this study, neither a commercially available nor free to use computerised CBT intervention was superior to usual GP care."
http://www.bmj.com/content/351/bmj.h5627
"What this study adds Supported cCBT does not substantially improve depression outcomes compared with usual GP care alone. In this study, neither a commercially available nor free to use computerised CBT intervention was superior to usual GP care."
http://www.bmj.com/content/351/bmj.h5627
Tuesday, November 17, 2015
NEJM - "Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease"
"Effect of PCI on Long-Term Survival in Patients with Stable Ischemic Heart Disease"
"CONCLUSIONS
"CONCLUSIONS
During an extended-follow-up of up to 15 years, we did not find a difference in survival between an initial strategy of PCI plus medical therapy and medical therapy alone in patients with stable ischemic heart disease. (Funded by the VA Cooperative Studies Program and others; COURAGE ClinicalTrials.gov number, NCT00007657.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1505532
Monday, November 16, 2015
JAMA - "Endovascular Thrombectomy for Acute Ischemic Stroke A Meta-analysis"
"Endovascular Thrombectomy for Acute Ischemic Stroke A Meta-analysis"
"Conclusions and Relevance Among patients with acute ischemic stroke, endovascular therapy with mechanical thrombectomy vs standard medical care with tPA was associated with improved functional outcomes and higher rates of angiographic revascularization, but no significant difference in symptomatic intracranial hemorrhage or all-cause mortality at 90 days."
http://jama.jamanetwork.com/article.aspx?articleid=2467553
"Conclusions and Relevance Among patients with acute ischemic stroke, endovascular therapy with mechanical thrombectomy vs standard medical care with tPA was associated with improved functional outcomes and higher rates of angiographic revascularization, but no significant difference in symptomatic intracranial hemorrhage or all-cause mortality at 90 days."
http://jama.jamanetwork.com/article.aspx?articleid=2467553
Friday, November 13, 2015
Weekly Guideline: "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 4: Systems of Care and Continuous Quality Improvement"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 4: Systems of Care and Continuous Quality Improvement"
http://circ.ahajournals.org/content/132/18_suppl_2/S397.full
http://circ.ahajournals.org/content/132/18_suppl_2/S397.full
Thursday, November 12, 2015
CIRC - "Dose–Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis"
"Dose–Response Relationship Between Physical Activity and Risk of Heart Failure A Meta-Analysis"
"Conclusions—There is an inverse dose–response relationship between PA and HF risk. Doses of PA in excess of the guideline-recommended minimum PA levels may be required for more substantial reductions in HF risk."
http://circ.ahajournals.org/content/132/19/1786.full
"Conclusions—There is an inverse dose–response relationship between PA and HF risk. Doses of PA in excess of the guideline-recommended minimum PA levels may be required for more substantial reductions in HF risk."
http://circ.ahajournals.org/content/132/19/1786.full
Wednesday, November 11, 2015
BMJ - "Physician spending and subsequent risk of malpractice claims: observational study"
"Physician spending and subsequent risk of malpractice claims: observational study"
"What this study adds Within specialty and after adjustment for patient characteristics, higher resource use by physicians is associated with fewer malpractice claims."
http://www.bmj.com/content/351/bmj.h5516-0
"What this study adds Within specialty and after adjustment for patient characteristics, higher resource use by physicians is associated with fewer malpractice claims."
http://www.bmj.com/content/351/bmj.h5516-0
Tuesday, November 10, 2015
NEJM - "Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma"
"Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma"
"CONCLUSIONS
"CONCLUSIONS
Among patients with previously treated advanced renal-cell carcinoma, overall survival was longer and fewer grade 3 or 4 adverse events occurred with nivolumab than with everolimus. (Funded by Bristol-Myers Squibb; CheckMate 025 ClinicalTrials.gov number,NCT01668784.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1510665
Monday, November 9, 2015
JAMA "Trends in Prescription Drug Use Among Adults in the United States From 1999-2012"
"Trends in Prescription Drug Use Among Adults in the United States From 1999-2012"
"Conclusions and Relevance In this nationally representative survey, significant increases in overall prescription drug use and polypharmacy were observed. These increases persisted after accounting for changes in the age distribution of the population. The prevalence of prescription drug use increased in the majority of, but not all, drug classes."
http://jama.jamanetwork.com/article.aspx?articleid=2467552
"Conclusions and Relevance In this nationally representative survey, significant increases in overall prescription drug use and polypharmacy were observed. These increases persisted after accounting for changes in the age distribution of the population. The prevalence of prescription drug use increased in the majority of, but not all, drug classes."
http://jama.jamanetwork.com/article.aspx?articleid=2467552
Friday, November 6, 2015
Weekly Guideline - "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 3: Ethical Issues"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 3: Ethical Issues"
http://circ.ahajournals.org/content/132/18_suppl_2/S383.full
http://circ.ahajournals.org/content/132/18_suppl_2/S383.full
Thursday, November 5, 2015
CIRC - "Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients"
CIRC - "Use of the Wearable Cardioverter Defibrillator in High-Risk Cardiac Patients"
"Conclusions—The WEARIT-II Registry demonstrates a high rate of sustained ventricular tachyarrhythmias at 3 months in at-risk patients who are not eligible for an implantable cardioverter defibrillator, and suggests that the WCD can be safely used to protect patients during this period of risk assessment."
http://circ.ahajournals.org/content/132/17/1613.abstract
"Conclusions—The WEARIT-II Registry demonstrates a high rate of sustained ventricular tachyarrhythmias at 3 months in at-risk patients who are not eligible for an implantable cardioverter defibrillator, and suggests that the WCD can be safely used to protect patients during this period of risk assessment."
http://circ.ahajournals.org/content/132/17/1613.abstract
Wednesday, November 4, 2015
BMJ - "Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)"
BMJ - "Liraglutide in people treated for type 2 diabetes with multiple daily insulin injections: randomised clinical trial (MDI Liraglutide trial)"
"What this study adds Adding liraglutide to multiple daily insulin injections in people with type 2 diabetes improves glycaemic control without an increased risk of hypoglycaemia, reduces body weight, and enables patients to lower their insulin doses."
http://www.bmj.com/content/351/bmj.h5364
"What this study adds Adding liraglutide to multiple daily insulin injections in people with type 2 diabetes improves glycaemic control without an increased risk of hypoglycaemia, reduces body weight, and enables patients to lower their insulin doses."
http://www.bmj.com/content/351/bmj.h5364
Tuesday, November 3, 2015
NEJM - "A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention"
NEJM - "A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention"
"CONCLUSIONS
"CONCLUSIONS
Oral nicotinamide was safe and effective in reducing the rates of new nonmelanoma skin cancers and actinic keratoses in high-risk patients. (Funded by the National Health and Medical Research Council; ONTRAC Australian New Zealand Clinical Trials Registry number, ACTRN12612000625875.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1506197
Monday, November 2, 2015
JAMA - "Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit The SPLIT Randomized Clinical Trial"
JAMA - "Effect of a Buffered Crystalloid Solution vs Saline on Acute Kidney Injury Among Patients in the Intensive Care Unit The SPLIT Randomized Clinical Trial"
"Conclusions and Relevance Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk of AKI. Further large randomized clinical trials are needed to assess efficacy in higher-risk populations and to measure clinical outcomes such as mortality."
http://jama.jamanetwork.com/article.aspx?articleid=2454911
"Conclusions and Relevance Among patients receiving crystalloid fluid therapy in the ICU, use of a buffered crystalloid compared with saline did not reduce the risk of AKI. Further large randomized clinical trials are needed to assess efficacy in higher-risk populations and to measure clinical outcomes such as mortality."
http://jama.jamanetwork.com/article.aspx?articleid=2454911
Friday, October 30, 2015
Weekly Guideline - "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 2: Evidence Evaluation and Management of Conflicts of Interest"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Part 2: Evidence Evaluation and Management of Conflicts of Interest"
http://circ.ahajournals.org/content/132/18_suppl_2/S368.full
http://circ.ahajournals.org/content/132/18_suppl_2/S368.full
Thursday, October 29, 2015
CIRC - "Rate-Control Treatment and Mortality in Atrial Fibrillation"
"Rate-Control Treatment and Mortality in Atrial Fibrillation"
"Conclusions—In this nationwide atrial fibrillation cohort, the risk of mortality was lower for patients receiving rate-control treatment with β-blockers or calcium channel blockers, and the use of β-blockers was associated with the largest risk reduction. Digoxin use was associated with greater mortality. Prospective, randomized trials are necessary to confirm these findings."
http://circ.ahajournals.org/content/132/17/1604.abstract
"Conclusions—In this nationwide atrial fibrillation cohort, the risk of mortality was lower for patients receiving rate-control treatment with β-blockers or calcium channel blockers, and the use of β-blockers was associated with the largest risk reduction. Digoxin use was associated with greater mortality. Prospective, randomized trials are necessary to confirm these findings."
http://circ.ahajournals.org/content/132/17/1604.abstract
Wednesday, October 28, 2015
BMJ - "Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS)"
"Risk of cancer from occupational exposure to ionising radiation: retrospective cohort study of workers in France, the United Kingdom, and the United States (INWORKS)"
"What this study adds The study provides a direct estimate of the association between protracted low dose exposure to ionising radiation and solid cancer mortality. Although high dose rate exposures are thought to be more dangerous than low dose rate exposures, the risk per unit of radiation dose for cancer among radiation workers was similar to estimates derived from studies of Japanese atomic bomb survivors. Quantifying the cancer risks associated with protracted radiation exposures can help strengthen the foundation for radiation protection standards."
http://www.bmj.com/content/351/bmj.h5359
"What this study adds The study provides a direct estimate of the association between protracted low dose exposure to ionising radiation and solid cancer mortality. Although high dose rate exposures are thought to be more dangerous than low dose rate exposures, the risk per unit of radiation dose for cancer among radiation workers was similar to estimates derived from studies of Japanese atomic bomb survivors. Quantifying the cancer risks associated with protracted radiation exposures can help strengthen the foundation for radiation protection standards."
http://www.bmj.com/content/351/bmj.h5359
Tuesday, October 27, 2015
NEJM - "A Randomized, Controlled Trial of Total Knee Replacement"
NEJM - "A Randomized, Controlled Trial of Total Knee Replacement"
"CONCLUSIONS
"CONCLUSIONS
In patients with knee osteoarthritis who were eligible for unilateral total knee replacement, treatment with total knee replacement followed by nonsurgical treatment resulted in greater pain relief and functional improvement after 12 months than did nonsurgical treatment alone. However, total knee replacement was associated with a higher number of serious adverse events than was nonsurgical treatment, and most patients who were assigned to receive nonsurgical treatment alone did not undergo total knee replacement before the 12-month follow-up. (Funded by the Obel Family Foundation and others; MEDIC ClinicalTrials.gov number, NCT01410409.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1505467
Monday, October 26, 2015
JAMA - (REVIEW) "Evaluation and Treatment of Pericarditis A Systematic Review"
JAMA - (REVIEW) "Evaluation and Treatment of Pericarditis A Systematic Review"
"Findings The etiology of pericarditis may be infectious (eg, viral and bacterial) or noninfectious (eg, systemic inflammatory diseases, cancer, and post–cardiac injury syndromes). Tuberculosis is a major cause of pericarditis in developing countries but accounts for less than 5% of cases in developed countries, where idiopathic, presumed viral causes are responsible for 80% to 90% of cases. The diagnosis is based on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and pericardial effusion. Certain features at presentation (temperature >38°C [>100.4°F], subacute course, large effusion or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) indicate a poorer prognosis and identify patients requiring hospital admission. The most common treatment for idiopathic and viral pericarditis in North America and Europe is NSAID therapy. Adjunctive colchicine can ameliorate the initial episode and is associated with approximately 50% lower recurrence rates. Corticosteroids are a second-line therapy for those who do not respond, are intolerant, or have contraindications to NSAIDs and colchicine. Recurrences may occur in 30% of patients without preventive therapy.
"Findings The etiology of pericarditis may be infectious (eg, viral and bacterial) or noninfectious (eg, systemic inflammatory diseases, cancer, and post–cardiac injury syndromes). Tuberculosis is a major cause of pericarditis in developing countries but accounts for less than 5% of cases in developed countries, where idiopathic, presumed viral causes are responsible for 80% to 90% of cases. The diagnosis is based on clinical criteria including chest pain, a pericardial rub, electrocardiographic changes, and pericardial effusion. Certain features at presentation (temperature >38°C [>100.4°F], subacute course, large effusion or tamponade, and failure of nonsteroidal anti-inflammatory drug [NSAID] treatment) indicate a poorer prognosis and identify patients requiring hospital admission. The most common treatment for idiopathic and viral pericarditis in North America and Europe is NSAID therapy. Adjunctive colchicine can ameliorate the initial episode and is associated with approximately 50% lower recurrence rates. Corticosteroids are a second-line therapy for those who do not respond, are intolerant, or have contraindications to NSAIDs and colchicine. Recurrences may occur in 30% of patients without preventive therapy.
Conclusions and Relevance Pericarditis is the most common form of pericardial disease worldwide and may recur in as many as one-third of patients who present with idiopathic or viral pericarditis. Appropriate triage and treatment with NSAIDs may reduce readmission rates for pericarditis. Treatment with colchicine can reduce recurrence rates."
http://jama.jamanetwork.com/article.aspx?articleid=2456172
Friday, October 23, 2015
Weekly Guideline "2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care"
"2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care"
"Part 1: Executive Summary"
http://circ.ahajournals.org/content/132/18_suppl_2/S315.full
"Part 1: Executive Summary"
http://circ.ahajournals.org/content/132/18_suppl_2/S315.full
Thursday, October 22, 2015
CIRC - "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis"
CIRC - "Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis"
"Conclusions—There is a continuum of cardiac involvement in systemic AL and ATTR amyloidosis. Transmural LGE is determined reliably by PSIR and represents advanced cardiac amyloidosis. The PSIR technique provides incremental information on outcome even after adjustment for known prognostic factors."
http://circ.ahajournals.org/content/132/16/1570.full
"Conclusions—There is a continuum of cardiac involvement in systemic AL and ATTR amyloidosis. Transmural LGE is determined reliably by PSIR and represents advanced cardiac amyloidosis. The PSIR technique provides incremental information on outcome even after adjustment for known prognostic factors."
http://circ.ahajournals.org/content/132/16/1570.full
Wednesday, October 21, 2015
BMJ - "Calcium intake and risk of fracture: systematic review"
BMJ - "Calcium intake and risk of fracture: systematic review"
"Conclusions Dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures. Evidence that calcium supplements prevent fractures is weak and inconsistent."
http://www.bmj.com/content/351/bmj.h4580
"Conclusions Dietary calcium intake is not associated with risk of fracture, and there is no clinical trial evidence that increasing calcium intake from dietary sources prevents fractures. Evidence that calcium supplements prevent fractures is weak and inconsistent."
http://www.bmj.com/content/351/bmj.h4580
Tuesday, October 20, 2015
NEJM - "A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas"
NEJM - "A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1500409
"CONCLUSIONS
Daily supplementation with vitamin D3 (1000 IU), calcium (1200 mg), or both after removal of colorectal adenomas did not significantly reduce the risk of recurrent colorectal adenomas over a period of 3 to 5 years. (Funded by the National Cancer Institute; ClinicalTrials.gov number, NCT00153816.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1500409
Monday, October 19, 2015
JAMA - "Early Physical Therapy vs Usual Care in Patients With Recent-Onset Low Back Pain A Randomized Clinical Trial"
JAMA - "Early Physical Therapy vs Usual Care in Patients With Recent-Onset Low Back Pain A Randomized Clinical Trial"
"Conclusions and Relevance Among adults with recent-onset LBP, early physical therapy resulted in statistically significant improvement in disability, but the improvement was modest and did not achieve the minimum clinically important difference compared with usual care."
http://jama.jamanetwork.com/article.aspx?articleid=2456165
"Conclusions and Relevance Among adults with recent-onset LBP, early physical therapy resulted in statistically significant improvement in disability, but the improvement was modest and did not achieve the minimum clinically important difference compared with usual care."
http://jama.jamanetwork.com/article.aspx?articleid=2456165
Friday, October 16, 2015
Weekly Guideline - 2015 AHA "Infective Endocarditis in Childhood: 2015 Update"
"AHA Scientific Statement
Infective Endocarditis in Childhood: 2015 Update"
http://circ.ahajournals.org/content/132/15/1487
Infective Endocarditis in Childhood: 2015 Update"
http://circ.ahajournals.org/content/132/15/1487
Thursday, October 15, 2015
CIRC - "Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation"
"Cryoballoon Versus Open Irrigated Radiofrequency Ablation in Patients With Paroxysmal Atrial Fibrillation"
"Conclusion—This large, prospective, randomized, controlled study demonstrates noninferiority of CB ablation versus RF ablation for treating patients with paroxysmal atrial fibrillation."
http://circ.ahajournals.org/content/132/14/1311.full
"Conclusion—This large, prospective, randomized, controlled study demonstrates noninferiority of CB ablation versus RF ablation for treating patients with paroxysmal atrial fibrillation."
http://circ.ahajournals.org/content/132/14/1311.full
Wednesday, October 14, 2015
BMJ - "Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study"
"Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study"
"Conclusions Discrepancies in published trial reports should no longer be assumed to be unimportant. Scientists, blinded to retraction status and with no specialist skill in the field, identify significantly more discrepancies in retracted than unretracted reports of clinical trials. Discrepancies could be an early and accessible signal of unreliability in clinical trial reports."
http://www.bmj.com/content/351/bmj.h4708
"Conclusions Discrepancies in published trial reports should no longer be assumed to be unimportant. Scientists, blinded to retraction status and with no specialist skill in the field, identify significantly more discrepancies in retracted than unretracted reports of clinical trials. Discrepancies could be an early and accessible signal of unreliability in clinical trial reports."
http://www.bmj.com/content/351/bmj.h4708
Tuesday, October 13, 2015
NEJM - "Calcium intake and bone mineral density: systematic review and meta-analysis"
"Calcium intake and bone mineral density: systematic review and meta-analysis"
"Conclusions Increasing calcium intake from dietary sources or by taking calcium supplements produces small non-progressive increases in BMD, which are unlikely to lead to a clinically significant reduction in risk of fracture."
http://www.bmj.com/content/351/bmj.h4183
"Conclusions Increasing calcium intake from dietary sources or by taking calcium supplements produces small non-progressive increases in BMD, which are unlikely to lead to a clinically significant reduction in risk of fracture."
http://www.bmj.com/content/351/bmj.h4183
Monday, October 12, 2015
JAMA - "Rehabilitation After Immobilization for Ankle Fracture The EXACT Randomized Clinical Trial"
"Rehabilitation After Immobilization for Ankle Fracture The EXACT Randomized Clinical Trial"
"Conclusions and Relevance A supervised exercise program and advice did not confer additional benefits in activity limitation or quality of life compared with advice alone for patients with isolated and uncomplicated ankle fracture. These findings do not support the routine use of supervised exercise programs after removal of immobilization for patients with isolated and uncomplicated ankle fracture."
http://jama.jamanetwork.com/article.aspx?articleid=2449186
"Conclusions and Relevance A supervised exercise program and advice did not confer additional benefits in activity limitation or quality of life compared with advice alone for patients with isolated and uncomplicated ankle fracture. These findings do not support the routine use of supervised exercise programs after removal of immobilization for patients with isolated and uncomplicated ankle fracture."
http://jama.jamanetwork.com/article.aspx?articleid=2449186
Friday, October 9, 2015
Weekly Guideline - 2015 AHA Endocarditis
"AHA Scientific Statement Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications"
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296
http://circ.ahajournals.org/content/early/2015/09/15/CIR.0000000000000296
Thursday, October 8, 2015
CIRC - "How Does Cardiovascular Disease First Present in Women and Men?"
"How Does Cardiovascular Disease First Present in Women and Men?
Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People"
http://circ.ahajournals.org/content/132/14/1320.full
Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People"
http://circ.ahajournals.org/content/132/14/1320.full
Wednesday, October 7, 2015
BMJ - "Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis"
"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis"
"Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori."
http://www.bmj.com/content/351/bmj.h4052
"Conclusion Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori."
http://www.bmj.com/content/351/bmj.h4052
Tuesday, October 6, 2015
NEJM - schemic Preconditioning for Heart Surgery
"A Multicenter Trial of Remote Ischemic Preconditioning for Heart Surgery"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1413579?query=featured_home
"CONCLUSIONS
Upper-limb RIPC performed while patients were under propofol-induced anesthesia did not show a relevant benefit among patients undergoing elective cardiac surgery. (Funded by the German Research Foundation; RIPHeart ClinicalTrials.gov number,NCT01067703.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1413579?query=featured_home
Monday, October 5, 2015
JAMA - "Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia"
"Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia"
"Conclusions and Relevance In this preliminary 10-week phase 2 randomized clinical trial of patients with probable Alzheimer disease, combination dextromethorphan-quinidine demonstrated clinically relevant efficacy for agitation and was generally well tolerated."
http://jama.jamanetwork.com/article.aspx?articleid=2442936
"Conclusions and Relevance In this preliminary 10-week phase 2 randomized clinical trial of patients with probable Alzheimer disease, combination dextromethorphan-quinidine demonstrated clinically relevant efficacy for agitation and was generally well tolerated."
http://jama.jamanetwork.com/article.aspx?articleid=2442936
Friday, October 2, 2015
Weekly Guideline - "2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society"
"2015 ACC/AHA/HRS Guideline
for the Management of Adult Patients With Supraventricular Tachycardia:
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society"
http://circ.ahajournals.org/content/early/2015/09/22/CIR.0000000000000311.full.pdf+html
for the Management of Adult Patients With Supraventricular Tachycardia:
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society"
http://circ.ahajournals.org/content/early/2015/09/22/CIR.0000000000000311.full.pdf+html
Thursday, October 1, 2015
CIRC - "Impact of Institutional Volume on Outcomes of Catheter Directed Thrombolysis in the Treatment of Acute Proximal Deep Vein Thrombosis A 6-Year US Experience (2005–2010)"
"Impact of Institutional Volume on Outcomes of Catheter Directed Thrombolysis in the Treatment of Acute Proximal Deep Vein Thrombosis A 6-Year US Experience (2005–2010)"
"Conclusions—In this observational study, we found that an increase in institutional volume of CDT was associated with lower in-hospital mortality and lower intracranial hemorrhage rates. Further studies are needed to assess whether standardization of CDT protocols across all institutions in the United States improves outcomes."
http://circ.ahajournals.org/content/132/12/1127.abstract
"Conclusions—In this observational study, we found that an increase in institutional volume of CDT was associated with lower in-hospital mortality and lower intracranial hemorrhage rates. Further studies are needed to assess whether standardization of CDT protocols across all institutions in the United States improves outcomes."
http://circ.ahajournals.org/content/132/12/1127.abstract
Wednesday, September 30, 2015
BMJ - "Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study"
"Frequency of discrepancies in retracted clinical trial reports versus unretracted reports: blinded case-control study"
"Conclusions Discrepancies in published trial reports should no longer be assumed to be unimportant. Scientists, blinded to retraction status and with no specialist skill in the field, identify significantly more discrepancies in retracted than unretracted reports of clinical trials. Discrepancies could be an early and accessible signal of unreliability in clinical trial reports."
http://www.bmj.com/content/351/bmj.h4708
"Conclusions Discrepancies in published trial reports should no longer be assumed to be unimportant. Scientists, blinded to retraction status and with no specialist skill in the field, identify significantly more discrepancies in retracted than unretracted reports of clinical trials. Discrepancies could be an early and accessible signal of unreliability in clinical trial reports."
http://www.bmj.com/content/351/bmj.h4708
Tuesday, September 29, 2015
NEJM - "Intravascular Complications of Central Venous Catheterization by Insertion Site"
"Intravascular Complications of Central Venous Catheterization by Insertion Site"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1500964?query=featured_home
"CONCLUSIONS
In this trial, subclavian-vein catheterization was associated with a lower risk of bloodstream infection and symptomatic thrombosis and a higher risk of pneumothorax than jugular-vein or femoral-vein catheterization. (Funded by the Hospital Program for Clinical Research, French Ministry of Health; ClinicalTrials.gov number,NCT01479153.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1500964?query=featured_home
Monday, September 28, 2015
JAMA - "Alignment of Do-Not-Resuscitate Status With Patients’ Likelihood of Favorable Neurological Survival After In-Hospital Cardiac Arrest"
"Alignment of Do-Not-Resuscitate Status With Patients’ Likelihood of Favorable Neurological Survival After In-Hospital Cardiac Arrest"
"Conclusions and Relevance Although DNR orders after in-hospital cardiac arrest were generally aligned with patients’ likelihood of favorable neurological survival, only one-third of patients with the worst prognosis had DNR orders. Patients with DNR orders had lower survival than those without DNR orders, including those with the best prognosis."
http://jama.jamanetwork.com/article.aspx?articleid=2442939
"Conclusions and Relevance Although DNR orders after in-hospital cardiac arrest were generally aligned with patients’ likelihood of favorable neurological survival, only one-third of patients with the worst prognosis had DNR orders. Patients with DNR orders had lower survival than those without DNR orders, including those with the best prognosis."
http://jama.jamanetwork.com/article.aspx?articleid=2442939
Friday, September 25, 2015
Weekly Guideline - "Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia"
"Risk Stratification for Arrhythmic Events in Patients With Asymptomatic Pre-Excitation: A Systematic Review for the 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia"
http://circ.ahajournals.org/content/early/2015/09/22/CIR.0000000000000309.full.pdf+html
http://circ.ahajournals.org/content/early/2015/09/22/CIR.0000000000000309.full.pdf+html
Thursday, September 24, 2015
CIRC - "Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke A Pilot Trial"
"Combination of the Immune Modulator Fingolimod With Alteplase in Acute Ischemic Stroke A Pilot Trial"
"Conclusions—In this pilot study, combination therapy of fingolimod and alteplase was well tolerated, attenuated reperfusion injury, and improved clinical outcomes in patients with acute ischemic stroke. These findings need to be tested in further clinical trials."
http://circ.ahajournals.org/content/132/12/1104.abstract
"Conclusions—In this pilot study, combination therapy of fingolimod and alteplase was well tolerated, attenuated reperfusion injury, and improved clinical outcomes in patients with acute ischemic stroke. These findings need to be tested in further clinical trials."
http://circ.ahajournals.org/content/132/12/1104.abstract
Wednesday, September 23, 2015
BMJ - "Consumption of spicy foods and total and cause specific mortality: population based cohort study"
"Consumption of spicy foods and total and cause specific mortality: population based cohort study"
"Conclusion In this large prospective study, the habitual consumption of spicy foods was inversely associated with total and certain cause specific mortality, independent of other risk factors of death."
http://www.bmj.com/content/351/bmj.h3942
"Conclusion In this large prospective study, the habitual consumption of spicy foods was inversely associated with total and certain cause specific mortality, independent of other risk factors of death."
http://www.bmj.com/content/351/bmj.h3942
Tuesday, September 22, 2015
NEJM - "Cyclosporine before PCI in Patients with Acute Myocardial Infarction"
"Cyclosporine before PCI in Patients with Acute Myocardial Infarction"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1505489
"CONCLUSIONS
In patients with anterior STEMI who had been referred for primary PCI, intravenous cyclosporine did not result in better clinical outcomes than those with placebo and did not prevent adverse left ventricular remodeling at 1 year. (Funded by the French Ministry of Health and NeuroVive Pharmaceutical; CIRCUS ClinicalTrials.gov number,NCT01502774; EudraCT number, 2009-013713-99.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1505489
Monday, September 21, 2015
JAMA - "Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement"
"Outcomes After Hip Fracture Surgery Compared With Elective Total Hip Replacement"
"Conclusions and Relevance In a large cohort of French patients, hip fracture surgery compared with elective THR was associated with a higher risk of in-hospital mortality after adjustment for age, sex, and measured comorbidities. Further studies are needed to define the causes for these differences."
http://jama.jamanetwork.com/article.aspx?articleid=2441262
"Conclusions and Relevance In a large cohort of French patients, hip fracture surgery compared with elective THR was associated with a higher risk of in-hospital mortality after adjustment for age, sex, and measured comorbidities. Further studies are needed to define the causes for these differences."
http://jama.jamanetwork.com/article.aspx?articleid=2441262
Friday, September 18, 2015
Weekly Guideline - 2015 AHA "Identification of Obesity and Cardiovascular Risk in Ethnically and Racially Diverse Populations"
"Identification of Obesity and Cardiovascular Risk in Ethnically and Racially Diverse Populations"
http://circ.ahajournals.org/content/132/5/457
http://circ.ahajournals.org/content/132/5/457
Thursday, September 17, 2015
CIRC - "Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy"
"Risk of Cardiomyopathy in Younger Persons With a Family History of Death from Cardiomyopathy"
"Conclusions—A family history of premature cardiomyopathy death was associated with an increase in risk of cardiomyopathy ranging from 6- to 400-fold, depending on age, kinship, gender and number of affected family members. Our general population-based results support recommendations for presymptomatic screening of relatives of cardiomyopathy patients."
http://circ.ahajournals.org/content/132/11/1013.abstract
"Conclusions—A family history of premature cardiomyopathy death was associated with an increase in risk of cardiomyopathy ranging from 6- to 400-fold, depending on age, kinship, gender and number of affected family members. Our general population-based results support recommendations for presymptomatic screening of relatives of cardiomyopathy patients."
http://circ.ahajournals.org/content/132/11/1013.abstract
Wednesday, September 16, 2015
BMJ - "Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial"
"Effect of bivalent human papillomavirus vaccination on pregnancy outcomes: long term observational follow-up in the Costa Rica HPV Vaccine Trial"
"Conclusions
There is no evidence that bivalent HPV vaccination affects the risk of miscarriage for pregnancies conceived less than 90 days from vaccination. The increased risk estimate for miscarriages in a subgroup of pregnancies conceived any time after vaccination may be an artifact of a thorough set of sensitivity analyses, but since a genuine association cannot totally be ruled out, this signal should nevertheless be explored further in existing and future studies."
http://www.bmj.com/content/351/bmj.h4358
"Conclusions
There is no evidence that bivalent HPV vaccination affects the risk of miscarriage for pregnancies conceived less than 90 days from vaccination. The increased risk estimate for miscarriages in a subgroup of pregnancies conceived any time after vaccination may be an artifact of a thorough set of sensitivity analyses, but since a genuine association cannot totally be ruled out, this signal should nevertheless be explored further in existing and future studies."
http://www.bmj.com/content/351/bmj.h4358
Tuesday, September 15, 2015
NEJM - "Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes"
"Bivalirudin or Unfractionated Heparin in Acute Coronary Syndromes"
"RESULTS
http://www.nejm.org/doi/full/10.1056/NEJMoa1507854
"RESULTS
The rate of major adverse cardiovascular events was not significantly lower with bivalirudin than with heparin (10.3% and 10.9%, respectively; relative risk, 0.94; 95% confidence interval [CI], 0.81 to 1.09; P=0.44), nor was the rate of net adverse clinical events (11.2% and 12.4%, respectively; relative risk, 0.89; 95% CI, 0.78 to 1.03; P=0.12). Post-PCI bivalirudin infusion, as compared with no infusion, did not significantly decrease the rate of urgent target-vessel revascularization, definite stent thrombosis, or net adverse clinical events (11.0% and 11.9%, respectively; relative risk, 0.91; 95% CI, 0.74 to 1.11; P=0.34)."
http://www.nejm.org/doi/full/10.1056/NEJMoa1507854
Monday, September 14, 2015
JAMA - "Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy"
"Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy"
"Conclusions and Relevance Among patients with diabetic nephropathy, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of finerenone compared with placebo resulted in improvement in the urinary albumin-creatinine ratio. Further trials are needed to compare finerenone with other active medications."
http://jama.jamanetwork.com/article.aspx?articleid=2432163
"Conclusions and Relevance Among patients with diabetic nephropathy, most receiving an angiotensin-converting enzyme inhibitor or an angiotensin receptor blocker, the addition of finerenone compared with placebo resulted in improvement in the urinary albumin-creatinine ratio. Further trials are needed to compare finerenone with other active medications."
http://jama.jamanetwork.com/article.aspx?articleid=2432163
Friday, September 11, 2015
Weekly Guideline - 2015 AHA / ADA "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence"
"Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence"
http://circ.ahajournals.org/content/132/8/691
http://circ.ahajournals.org/content/132/8/691
Thursday, September 10, 2015
CIRC - "Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines"
"Utility of Nontraditional Risk Markers in Individuals Ineligible for Statin Therapy According to the 2013 American College of Cardiology/American Heart Association Cholesterol Guidelines"
"Conclusions—In this generally low-risk population sample, a large proportion of ASCVD events occurred among adults with a 10-year cPCE risk <7.5%. We found that the coronary artery calcium score, high-sensitivity C-reactive protein, family history of ASCVD, and ankle-brachial index recommendations by the American College of Cardiology/American Heart Association cholesterol guidelines (Class IIB) identify small subgroups of asymptomatic population with a 10-year cPCE risk <7.5% but with observed ASCVD event rates >7.5% who may warrant statin therapy considerations."
http://circ.ahajournals.org/content/132/10/916.full
"Conclusions—In this generally low-risk population sample, a large proportion of ASCVD events occurred among adults with a 10-year cPCE risk <7.5%. We found that the coronary artery calcium score, high-sensitivity C-reactive protein, family history of ASCVD, and ankle-brachial index recommendations by the American College of Cardiology/American Heart Association cholesterol guidelines (Class IIB) identify small subgroups of asymptomatic population with a 10-year cPCE risk <7.5% but with observed ASCVD event rates >7.5% who may warrant statin therapy considerations."
http://circ.ahajournals.org/content/132/10/916.full
Wednesday, September 9, 2015
BMJ - "Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care"
"Diagnostic prediction models for suspected pulmonary embolism: systematic review and independent external validation in primary care"
"Conclusions
Five diagnostic pulmonary embolism prediction models that are easily applicable in primary care were validated in this setting. Whereas efficiency was comparable for all rules, the Wells rules gave the best performance in terms of lower failure rates."
http://www.bmj.com/content/351/bmj.h4438
"Conclusions
Five diagnostic pulmonary embolism prediction models that are easily applicable in primary care were validated in this setting. Whereas efficiency was comparable for all rules, the Wells rules gave the best performance in terms of lower failure rates."
http://www.bmj.com/content/351/bmj.h4438
Tuesday, September 8, 2015
NEJM - "Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy"
"Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1406761
"CONCLUSIONS
Patients with takotsubo cardiomyopathy had a higher prevalence of neurologic or psychiatric disorders than did those with an acute coronary syndrome. This condition represents an acute heart failure syndrome with substantial morbidity and mortality. (Funded by the Mach-Gaensslen Foundation and others; ClinicalTrials.gov number,NCT01947621.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1406761
Monday, September 7, 2015
JAMA - "Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage"
"Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage"
"Conclusions and Relevance In this observational single-center cohort study of ICH survivors, reported BP measurements suggesting inadequate BP control during follow-up were associated with higher risk of both lobar and nonlobar ICH recurrence. These data suggest that randomized clinical trials are needed to address the benefits and risks of stricter BP control in ICH survivors."
http://jama.jamanetwork.com/article.aspx?articleid=2432164
"Conclusions and Relevance In this observational single-center cohort study of ICH survivors, reported BP measurements suggesting inadequate BP control during follow-up were associated with higher risk of both lobar and nonlobar ICH recurrence. These data suggest that randomized clinical trials are needed to address the benefits and risks of stricter BP control in ICH survivors."
http://jama.jamanetwork.com/article.aspx?articleid=2432164
Friday, September 4, 2015
Weekly Guideline - 2015 "NASPGHAN Guideline for the Diagnosis and Treatment of Celiac Disease in Children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition"
"Guideline for the Diagnosis and Treatment of Celiac Disease
in Children: Recommendations of the North American Society
for Pediatric Gastroenterology, Hepatology and Nutrition"
http://www.naspghan.org/files/documents/pdfs/cme/jpgn/Management_of_Ingested_Foreign_Bodies_in_Children_.28.pdf
http://www.naspghan.org/files/documents/pdfs/cme/jpgn/Management_of_Ingested_Foreign_Bodies_in_Children_.28.pdf
Thursday, September 3, 2015
CIRC - "Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation"
"Extracranial Systemic Embolic Events in Patients With Nonvalvular Atrial Fibrillation"
"Conclusions—SEE constituted 11.5% of clinically recognized thromboembolic events in patients with atrial fibrillation and was associated with high morbidity and mortality. SEE mortality was comparable to that of ischemic stroke and varied by anatomic site."
http://circ.ahajournals.org/content/132/9/796.abstract
"Conclusions—SEE constituted 11.5% of clinically recognized thromboembolic events in patients with atrial fibrillation and was associated with high morbidity and mortality. SEE mortality was comparable to that of ischemic stroke and varied by anatomic site."
http://circ.ahajournals.org/content/132/9/796.abstract
Wednesday, September 2, 2015
BMJ - "Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data"
"Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data"
"Conclusions Digoxin is associated with a neutral effect on mortality in randomised trials and a lower rate of admissions to hospital across all study types. Regardless of statistical analysis, prescription biases limit the value of observational data."
http://www.bmj.com/content/351/bmj.h4451
"Conclusions Digoxin is associated with a neutral effect on mortality in randomised trials and a lower rate of admissions to hospital across all study types. Regardless of statistical analysis, prescription biases limit the value of observational data."
http://www.bmj.com/content/351/bmj.h4451
Tuesday, September 1, 2015
NEJM - "Screening for Occult Cancer in Unprovoked Venous Thromboembolism"
"Screening for Occult Cancer in Unprovoked Venous Thromboembolism"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1506623
"CONCLUSIONS
The prevalence of occult cancer was low among patients with a first unprovoked venous thromboembolism. Routine screening with CT of the abdomen and pelvis did not provide a clinically significant benefit. (Funded by the Heart and Stroke Foundation of Canada; SOME ClinicalTrials.gov number, NCT00773448.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1506623
Monday, August 31, 2015
JAMA - "Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial"
"Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial"
"Conclusions and Relevance Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide (3.0 mg) daily, compared with placebo, resulted in weight loss over 56 weeks. Further studies are needed to evaluate longer-term efficacy and safety."
http://jama.jamanetwork.com/article.aspx?articleid=2428956
"Conclusions and Relevance Among overweight and obese participants with type 2 diabetes, use of subcutaneous liraglutide (3.0 mg) daily, compared with placebo, resulted in weight loss over 56 weeks. Further studies are needed to evaluate longer-term efficacy and safety."
http://jama.jamanetwork.com/article.aspx?articleid=2428956
Friday, August 28, 2015
Weekly Guideline - 2015 AAP "The Role of the Pediatrician in Primary Prevention of Obesity"
"The Role of the Pediatrician in Primary Prevention of Obesity"
http://pediatrics.aappublications.org/content/136/1/e275.abstract?rss=1
http://pediatrics.aappublications.org/content/136/1/e275.full.pdf+html (PDF)
http://pediatrics.aappublications.org/content/136/1/e275.abstract?rss=1
http://pediatrics.aappublications.org/content/136/1/e275.full.pdf+html (PDF)
Thursday, August 27, 2015
CIRC - "Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease"
"Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease"
"Conclusions
—More than a quarter of the patients in ARISTOTLE with nonvalvular atrial fibrillation had moderate or severe valvular heart disease. There was no evidence of a differential effect of apixaban over warfarin in reducing stroke or systemic embolism, causing less bleeding, and reducing death in patients with and without valvular heart disease."
http://circ.ahajournals.org/content/132/8/624.abstract
"Conclusions
—More than a quarter of the patients in ARISTOTLE with nonvalvular atrial fibrillation had moderate or severe valvular heart disease. There was no evidence of a differential effect of apixaban over warfarin in reducing stroke or systemic embolism, causing less bleeding, and reducing death in patients with and without valvular heart disease."
http://circ.ahajournals.org/content/132/8/624.abstract
Wednesday, August 26, 2015
BMJ - "Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis"
"Comparative effectiveness and tolerance of treatments for Helicobacter pylori: systematic review and network meta-analysis"
"Conclusion
Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori."
http://www.bmj.com/content/351/bmj.h4052
"Conclusion
Comparison of different eradication treatments for H pylori showed that concomitant treatments, 10 or 14 days of probiotic supplemented triple treatment, 10 or 14 days of levofloxacin based triple treatment, 14 days of hybrid treatment, and 10 or 14 days of sequential treatment might be better alternatives for the eradication of H pylori."
http://www.bmj.com/content/351/bmj.h4052
Tuesday, August 25, 2015
NEJM - "Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial"
"Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes The SCALE Diabetes Randomized Clinical Trial"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1506623
"CONCLUSIONS
The prevalence of occult cancer was low among patients with a first unprovoked venous thromboembolism. Routine screening with CT of the abdomen and pelvis did not provide a clinically significant benefit. (Funded by the Heart and Stroke Foundation of Canada; SOME ClinicalTrials.gov number, NCT00773448.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1506623
Monday, August 24, 2015
JAMA - "Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence"
"Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence"
"Conclusions and Relevance Among high school students in Los Angeles, those who had ever used e-cigarettes at baseline compared with nonusers were more likely to report initiation of combustible tobacco use over the next year. Further research is needed to understand whether this association may be causal."
http://jama.jamanetwork.com/article.aspx?articleid=2428954
"Conclusions and Relevance Among high school students in Los Angeles, those who had ever used e-cigarettes at baseline compared with nonusers were more likely to report initiation of combustible tobacco use over the next year. Further research is needed to understand whether this association may be causal."
http://jama.jamanetwork.com/article.aspx?articleid=2428954
Friday, August 21, 2015
Weekly Guideline - 2012 "NASPGHAN Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents"
"NASPGHAN Practice Guidelines: Diagnosis and Management of Hepatitis C Infection in Infants, Children, and Adolescents"
http://www.naspghan.org//files/documents/pdfs/position-papers/NASPGHAN_Practice_Guidelines___Diagnosis_and.30[1].pdf
http://www.naspghan.org//files/documents/pdfs/position-papers/NASPGHAN_Practice_Guidelines___Diagnosis_and.30[1].pdf
Thursday, August 20, 2015
CIRC - "Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death"
"Arrhythmic Mitral Valve Prolapse and Sudden Cardiac Death"
"Conclusions—MVP is an underestimated cause of arrhythmic SCD, mostly in young adult women. Fibrosis of the papillary muscles and inferobasal left ventricular wall, suggesting a myocardial stretch by the prolapsing leaflet, is the structural hallmark and correlates with ventricular arrhythmias origin. Contrast-enhanced cardiac magnetic resonance may help to identify in vivo this concealed substrate for risk stratification."
http://circ.ahajournals.org/content/132/7/556.full
"Conclusions—MVP is an underestimated cause of arrhythmic SCD, mostly in young adult women. Fibrosis of the papillary muscles and inferobasal left ventricular wall, suggesting a myocardial stretch by the prolapsing leaflet, is the structural hallmark and correlates with ventricular arrhythmias origin. Contrast-enhanced cardiac magnetic resonance may help to identify in vivo this concealed substrate for risk stratification."
http://circ.ahajournals.org/content/132/7/556.full
Wednesday, August 19, 2015
BMJ - "Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies"
"Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: systematic review and meta-analysis of observational studies"
"Conclusions Saturated fats are not associated with all cause mortality, CVD, CHD, ischemic stroke, or type 2 diabetes, but the evidence is heterogeneous with methodological limitations. Trans fats are associated with all cause mortality, total CHD, and CHD mortality, probably because of higher levels of intake of industrial trans fats than ruminant trans fats. Dietary guidelines must carefully consider the health effects of recommendations for alternative macronutrients to replace trans fats and saturated fats."
http://www.bmj.com/content/351/bmj.h3978
"Conclusions Saturated fats are not associated with all cause mortality, CVD, CHD, ischemic stroke, or type 2 diabetes, but the evidence is heterogeneous with methodological limitations. Trans fats are associated with all cause mortality, total CHD, and CHD mortality, probably because of higher levels of intake of industrial trans fats than ruminant trans fats. Dietary guidelines must carefully consider the health effects of recommendations for alternative macronutrients to replace trans fats and saturated fats."
http://www.bmj.com/content/351/bmj.h3978
Tuesday, August 18, 2015
NEJM - "Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma"
"Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma"
"CONCLUSIONS
http://www.nejm.org/doi/full/10.1056/NEJMoa1505654
"CONCLUSIONS
Patients with relapsed or refractory multiple myeloma who received a combination of elotuzumab, lenalidomide, and dexamethasone had a significant relative reduction of 30% in the risk of disease progression or death. (Funded by Bristol-Myers Squibb and AbbVie Biotherapeutics; ELOQUENT-2 ClinicalTrials.gov number,NCT01239797.)"
http://www.nejm.org/doi/full/10.1056/NEJMoa1505654
Subscribe to:
Posts (Atom)